Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 681-689

  El Mansari, Mostafa ^a   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT1D autoreceptors; Frontal cortex; Hippocampus; Mesencephalic raphe; Monoamine oxidase inhibition; N ethylmaleimide; Selective 5 HT reuptake blockade; Tetrodotoxin; 3H 5 HT release

Indexed keywords

5 METHOXYTRYPTAMINE; ALKYLATING AGENT; AMINE OXIDASE (FLAVIN CONTAINING); BEFLOXATONE; BRAIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOAMINE OXIDASE INHIBITOR; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N ETHYLMALEIMIDE; PAROXETINE; POTASSIUM ION; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ENZYME INHIBITION; FRONTAL CORTEX; GUINEA PIG; HIPPOCAMPUS; ISOTOPE LABELING; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC NERVE;

ANIMALS; AUTORECEPTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; GUINEA PIGS; HIPPOCAMPUS; MALE; RAPHE NUCLEI; RECEPTORS, SEROTONIN; SEROTONIN; SUMATRIPTAN;

EID: 0029892782     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15454.x     Document Type: Article

References (44)

1. ADELL, A. & ARTIGAS, F. (1991). Differential effects of clomiparamine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's. Arch. Pharmacol., 343, 237-244.
2. AGHAJANIAN, G., SPROUSE, J. & RASMUSSEN, K. (1987). Physiology of the mesencephalic serotonin system. In Psychopharmacology: The Third Generation of Progress, ed. Meltzer, H.Y. pp 141-149, New York: Raven Press.
3. BAUMANN, P.A. & WALDMEIER, P.C. (1981). Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's. Arch. Pharmacol., 317, 36-43.
4. BLIER, P. (1991). Terminal serotonin autoreceptor function in rat hippocampus is not modified by pertussis and cholera toxins. Nauny-Schmiedeberg's. Arch. Pharmacol., 344, 160-166.
5. 3 receptor which modulates the release of 5-HT in the guinea-pig brain. Br. J. Pharmacol., 108, 13-22.
6. BLIER, P. & BOUCHARD, C (1994). Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br. J. Pharmacol., 113, 485-495.
7. 3H]-5-HT release in the guinea pig hypothalamus are not autoreceptors. Synapse, 15, 143-148.
8. 1F receptor mesenger RNA in rodent and primate brain. Neuropharmacol., 33, 367-386.
9. CRAVEN, R., GRAHAME-SMITH, D. & NEWBERRY, N. (1994). WAY-100635 and GR 127935: Effects on 5-hydroxytryptamine-containing neurones. Eur. J. Pharmacol., 271, R1-R3.
10. 1D autoreceptors. Br. J. Pharmacol., 114, 1107-1109.
11. EL MANSARI, M., BOUCHARD, C. & BLIER, P. (1995). Alteration of serotonin release in the guinea-pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacol., 13, 117-127.
12. 1B binding sites. Naunyn-Schmiedeberg's. Arch. Pharmacol., 332, 1-7.
13. 1A receptors. Eur. J. Pharmacol., 237, 283-291.
14. 3H]hydroxytryptamine in slices of the human neocortex. J. Neurochem., 59, 1293-1301.
15. GALZIN, A.M., MORET, C., VERZIER, B. & LANGER, S.Z. (1985). Interaction between tricyclic and notricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther., 235, 200-210.
16. 1D serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors. Mol. Cell. Neurosci., 3, 578-587.
17. 1D-type serotonin receptor. Mol. Pharmacol., 40, 143-148.
18. 1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein. J. Neurochem., 51, 1906-1912.
19. HERTTING, G., WURSTER, S., GEBICKE-HÄRTER, S., ALLGAIER, C. (1988). Participation of regulatory G-proteins and protein kinase C in the modulation of transmitter release in hippocampus. In Modulation of Synaptic Transmission and Plasticity in Nervous System. ed. Hertting, G. & Spatz H.-C. pp. 147-164. Berlin-Heidelberg: Springer Verlag.
20. 3 Antagonists and Benzodiazepines: their Comparative Behavioural Pharmacology. ed. Rodgers, R.J. & Cooper, S.J. pp. 31-57. Chichester: John Wiley.
21. HOYER, D. & MIDDLEMISS, D.N. (1989). Species differences in the pharmacology of terminal 5-HT autoreceptor in mammalian brain. Trends Pharmacol. Sci., 10, 130-132.
22. 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behavior in the guinea-pig. Neuropharmacol., 34, 383-392.
23. INNIS, R.B. & AGHAJANIAN, G.K. (1987). Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurones in rat substancia nigra. Brain Res., 411, 139-143.
24. B-induced hyperpolarization of rat dorsal neurons. Brain Res., 459, 27-36.
25. JACOBS, B.L. (1986). Single unit activity of brain monoamines-containing neurones in freely moving animals. N. Y. Acad. Sci., 473, 70-77.
26. 1B receptor agonist, CP94253. Drug Dev. Res., 26, 241-250.
27. 1D in the rabbit and guinea pig brain cortex. Naunyn-Schmiedeberg's. Arch. Pharmacol., 343, 353-364.
28. 1D autoreceptors in human cerebral cortex. J. Neurochem., 60, 1179-1182.
29. 1 receptor agonist, RU24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol., 37, 434-437.
30. 2-adrenoceptors on 5-HT terminals following long-term treatment with drugs that increase noradrenaline synaptic availability. Neuropsychopharmacol., 10, 41-51.
31. 1A WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Neuropharmacol., 33, 61-66.
32. 1D receptor mRNA expression in the rat brain. Soc. Neurosci. Abst., 20, 1163.
33. 1D receptors: Effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration. J. Pharmacol. Exp. Ther., 276, 697-707.
34. 1D receptors. Soc. Neurosc. Abst., 19, 216.
35. 1D receptors regulate 5-HT release in the rat raphe nuclei: in vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacol., 13, 249-260.
36. 1D subtype is negatively coupled to adenylate cyclase in calf sustantia nigra. Naunyn-Schmiedeberg's. Arch. Pharmacol., 337, 602-608.
37. 1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacol., 34, 377-382.
38. STARKE, K., GÖTHERT, M. & KILBINGER, H. (1989). Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 864-988.
39. 1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus. Neuropharmacol., 33, 393-402.
40. 1D receptors in guinea-pig and pigeon brain, Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's. Arch. Pharmacol., 340, 479-485.
41. 1Dβ. Proc. Natl. Acad. Sci. U.S.A., 89, 3630-3634.
42. 1D receptors in the guinea-pig brain. Neuropharmacol., 32, 205-208.
43. 3H]-5-hydroxytryptamine release in guinea-pig hippocampus. Naunyn-Schmiedeberg's. Arch. Pharmacol., 345, 696-699.
44. 1Dβ receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol. Pharmacol., 44, 575-582.